Preview

Российский вестник перинатологии и педиатрии

Расширенный поиск

Метаболический портрет детей с ожирением

Полный текст:

Об авторах

С. И. Малявская
ГБОУ ВПО «Северный государственный медицинский университет» Минздрава России, Архангельск
Россия

д.м.н., проф., зав. кафедрой педиатрии, проректор по НИР Северного государственного медицинского университета



А. В. Лебедев
ГБОУ ВПО «Северный государственный медицинский университет» Минздрава России, Архангельск
Россия
к.м.н., доцент кафедры патологической физиологии указанного учреждения


Список литературы

1. Zimmeta P., Albertib К. G., Kaufmanc F. et al. The metabolic syndrome in children and adolescents — an IDF consensus report. Pediatric Diabetes 2007; 8: 5: 299-306.

2. Ни G., Oiao O., Tuomilehto J. Prevalence of the Metabolic Syndrome and Its Relation to All-Cause and Cardiovascular Mortality in Nondiabetic European Men and Women. Arch Intern Med 2004; 164: 1066-1076.

3. Garni A.S., Witt B.J., Howard O.E. Metabolic syndrome and risk of incident cardiovascular events and death. Asystematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007; 49: 403-414.

4. Hubert H.B., Feinleib M., McNamara P.M. et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 969-977.

5. McCrindle B.W., Urbina E.M., Dennison B.A. et al. Scientific Statement From the American Heart. Association Atherosclerosis, Hypertension and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, With the Council on Cardiovascular Nursing. Circulation 2007; 115: 1948-1967.

6. Профилактика сердечно-сосудистых заболеваний в детском и подростковом возрасте. Российские рекомендации. Рос кардиолжурн 2012; 6: Приложение 1: 1—40. (Prevention of cardiovascular disease in childhood and adolescence. Russian recommendations. Roskardiolzhurn2012; 6: Suppl 1:1—40).

7. Малявская СИ., Дворяшина И.В., Терновская В.А Метаболический инсулинорезистентный синдром: диагностика, клиническое значение, педиатрические аспекты. Архангельск 2004; 222. (Malyavskaya S.I., Dvoryashina I.V., Ter-novskaya V.A. Insulinresistant metabolic syndrome: diagnosis, clinical significance, pediatric aspects. ArkhangeFsk 2004; 222.)

8. Малявская СИ. Педиатрический метаболический синдром: состояние высокого риска. Педиатрия 2010; 89: 4: 119—122. (Malyavskaya S.I. Pediatric metabolic syndrome: the state of high risk. Pediatriya 2010; 89: 4: 119-122.)

9. Calcaterra V., Klersy C, Muratori T. et al. Prevalence of metabolic syndrome in children and adolescents with varying degrees of obesity. Clin Endocrinol 2008; 68: 6: 868-872.

10. Ahrens O.W., Moreno L.A., Marild S. et al. Metabolic syndrome in young children: definitions and results of the IDEF-ICS study. Intern J Obes 2014; 38: S4-S14.

11. Чумакова Г.А., Веселовская Н.Г., Гриценко О.В. и др. Метаболический синдром: сложные и нерешенные проблемы. Рос кардиол журн 2014; 3: 63—71. (Chumako-va G.A., Veselovskaya N.G., Gritsenko O.V. et al. Metabolic syndrome: a challenging and unsolved problems. Ros kardiol zhurn2014; 3: 63-71.)

12. Козлова Л.В., Бекезин В.В., Козлов СБ. и др. Метаболический синдром у детей и подростков с ожирением: диагностика, критерии рабочей классификации, особенности лечения. Педиатрия 2009; 88: 6: 142-150. (Kozlova L.V., Bekezin V.V., Kozlov S.B. et al. Metabolic syndrome in children and adolescents with obesity: diagnosis, criteria working classification, peculiarities of treatment. Pediatriya 2009; 88: 6: 142-150.)

13. Bjorntorp P. Visceral Obesity: "Civilization Syndrome". Obes Res 1993; 1: 3: 206-222.

14. Kvist H, Chowdhury V.B., Grandgard U. et al. Total and visceral adipose-tissue volumes derived from measurement with computed tomography in adult men and women: predictive equations. AmerJ Clin Nutr 1988; 48: 1351-1361.

15. Teixeira T.F.S., Alves R.D.M., Moreira A.P.B. et al. Main characteristics of metabolically obese normal weight and met-abolically healthy obese phenotypes. Nutrition Reviews 2015; 73: 3: 175-190.

16. Blxxher S., Schwarz P. Metabolically healthy obesity from childhood to adulthood — Does weight status alone matter? Metabolism 2014; 63: 9: 1084-1092.

17. Гинзбург М.М., Крюков HH Ожирение. Влияние на развитие метаболического синдрома. Профилактика и лечение. М: Медпрактика 2002; 128. (Ginzburg M.M., KryukovN.N. Ozhirenie. Influence on the development of metabolic syndrome. Prevention and treatment. M: Medpraktika2002; 128.)

18. Берштпейн Л.М., Коваленко ИГ «Метаболически здоровые» лица с ожирением и метаболические признаки ожирения у лиц с нормальной массой тела: что за этим стоит? Проблэндокринол2010; 3: 48—51. (BershteynL.M., Kova-lenko I.G. «Metabolically healthy» individuals with obesity and metabolic signs of obesity in persons with normal body weight: what's in it?) Probl endokrinol 2010; 3:48-51.)

19. Vague J. La differentiation sexuelle, facteur determinant des formes del'obesite. Press Med 1947; 55: 339-340.

20. Ruderman N.B., Schneider S.H., Berchtold P. The metabolically obese, normal weight individual. Am J Clin Nutr 1981; 34: 1617-1621.

21. Reaven G.M. Banting lecture 1988. Role of insulin resis-tance in human disease. Diabetes 1988; 37: 1595-1607.

22. Bjorntorp P. The regulation of adipose tissue distribution in humans. Int J Obes 1996; 20: 4: 291-302.

23. Bjorntorp P. Regional patterns of fat distribution. Ann Intern Med 1985; 103: 994-995.

24. Carey D.G.P. Abdominal obesity. Curr Opin Lipidol 1998; 9: 35-40.

25. Sjostrom CD., Fissner Г., Sjostrom F. Relationships between changes in body composition and changes in cardiovascular risk factors: the SOS intervention study. Obes Res 1997; 5: 6: 519-530.

26. Ruderman N., Chisholm D., Pi-Sunyer X. et al. The metabolically obese, normal-weight individual revisited. Diabetes 1998; 47: 699-713.

27. Rishi P. Is it Finally Time to Dispel the Concept of Metabol-ically-Healthy Obesity? J Amer College Cardiol 2014; 63: 24: 2687-2688.

28. Norbert S., Hans-Ulrich H, Frank H.B. et al. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabet Endocrinol 2013; 1: 2: 152—162.

29. Allan C.A., Strauss B.J., McFachlan R.I. Body composition, metabolic syndrome and testosterone in ageing men. Int J Im-pot Res 2007; 19: 448-457.

30. Succurro E., MariniM.A., Frontoni S. et al. Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals. Obesity 2008; 16: 1881-1886."

31. Barter P., McPherson Y.R., Song К et al. Serum insulin and inflammatory markers in overweight individuals with and without dyslipidemia. J Clin Endocrinol Metab 2007; 92: 6: 2041-2045.

32. Karelis A.D., Faraj M., Bastard J.P. et al. The metabolicafly healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005; 90: 7: 4145-4150.

33. Karelis A.D., St-Pierre D.H., Conus F. et al. Metabolic and body composition factors in subgroups of obesity. J Clin Endocrinol Metab 2004; 89: 8: 2569-2575.

34. Thalmann S., Meier C.A. Local adipose tissue depots as cardiovascular risk factors. Cardiovasc Res 2007; 75: 4: 690—701.

35. ShaharyarS., Roberson F.F., JamalO. etal. Obesity and metabolic phenotypes (metabolicafly healthy and unhealthy variants) are significantly associated with prevalence of elevated C-reactive protein and hepatic steatosis in a Large Healthy Brazilian Population. J Obes 2015; 2015: http://dx.doi. org/10.1155/2015/178526.

36. TchernofA., DespresJ.-P. Pathophysiology of Human Visceral Obesity: An Update. Physiol Rev Publ 2013; 93: 1: 359-404.

37. Rosen E.D., Spiegelman B.M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006; 444: 7121: 847-853.

38. Kelley D.E., Leland T.F., Troost F. et al. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab 2000; 278: 5: E941-E948.

39. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005; 115: 5: 911-920.

40. Romero-Corral A., Somers V.K., Sierra-Johnson J. et al. Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J 2010; 31: 6:737—746.

41. Kramer C.K., Zinman В., Retnakaran R. Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Ann Intern Med 2013; 159: 11: 758-769.

42. Wet-Ostaptchouk J.V., Nuotio M.L., Slagter S.N. et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis often large cohort studies. BMC Endocrine Dis 2014; 1: 9: http://www. biomedcentral.com/1472-6823/14/9.

43. Denis G.V., Obin M.S. «Metabolically healthy obesity»: origins and implications. Mol Aspects Med 2013; 34: 1: 59—70.

44. Rey-L6pez, J.P., de Rezende L.F., Pastor-Valero M. et al. The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used. Obes Rev. 2014; 10: 781-790.

45. Blither M. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol 2010; 21: 1: 38-43.

46. Stefan N., Schick F., Hating H.U. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med 2014; 371: 23: 2236-2237.

47. Rosito G.A., Massaro J.M., Hoffmann U. et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 2008; 117: 5: 605—613.

48. Бердышева О.И., Вахлова И.В., Зайкова И.О. и др. Ожирение и метаболический синдром у детей. Урал мед журн 2011; 7: 102-106. (Berdysheva O.I., Vakhlova I.V., Zayko-va I.O. et al. Obesity and metabolic syndrome in children. Ural med zhurn 2011; 7: 102-106.)

49. Fox C.S., Massaro J.M., Hoffmann U. et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116: 1: 39-48.

50. Oliveros E., Somers V.K., Sochor O. et al. The Concept of Normal Weight Obesity. Prog Cardiovasc Dis 2014; 56: 4: 426-433.

51. Shah R.V., Murthy V.L., Abbasi S.A. et al. Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study. JACC Cardiovasc Imag2014; 12:1221-1235.

52. Flynn J. Metabolic Syndrome as a Predictor of Cardivascular Risk in Children and Adolescents. Am J Hypertens 2007; 20: 8: 883.

53. Shargorodsky M. Vascular Impact of Metabolic Syndrome in Subjects with Normal Weight, Overweight, or Obesity: Is Normal Weight Sufficient for Vascular Health? J Am Coll Nutr 2015; 24: 1-6.

54. Bradshaw P.T., Monda K.L., Stevens J. Metabolic Syndrome in Healthy Obese, Overweight and Normal Weight Individuals: The Atherosclerosis Risk in Communities Study. Obesity 2013; 21: 203-209.

55. Qorbani M., Kelishadi R., Farrokhi-Khajeh-Pasha Y. et al. Association of Anthropometric Measures with Cardiovascular Risk Factors and Metabolic Syndrome in Normal-Weight Children and Adolescents: The CASPIAN III Study. Obes Facts 2013; 6: 483-492.

56. Surya M., Artham M.D., Lavie C.J. Obesity and hypertension, heart failure, and coronary heart disease-risk factor, paradox and recommendations for weight loss. Ochsner J2009; 9: 3:124—132.

57. De Schutter A., Lavie C.J., Patel D.A. et al. Obesity paradox and the heart: which indicator of obesity best describes this complex relationship? Curr Opin Clin Nutr Metab Care 2013; 16:5:517-524.

58. Huang В., Rodreiguez, B.L., Burchfiel CM. et al. Associations of adiposity with prevalent coronary heart disease among elderly men: the Honolulu Heart Program. Int J Obes Relat Metab Disord 1997; 21: 5: 340-348.

59. Cole T.J., Bellizzi M.C., Flegal KM. et al. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000; 320: 1240.

60. Малявская СИ., Лебедев А.В., Терновская В.А. Значение хронической бессимптомной гиперурикемии как маркера атерогенного риска у детей. Кардиология 2007; 47: 3: 62—66. (Malyavskaya S.I., Lebedev A.V., Ternovskaya V.A. The significance of asymptomatic chronic hyperuricemia as a marker of atherogenic risk in children. Kardiologiya 2007; 47: 3: 62—66.)


Рецензия

Для цитирования:


Малявская С.И., Лебедев А.В. Метаболический портрет детей с ожирением. Российский вестник перинатологии и педиатрии. 2015;60(6):73-81.

For citation:


Malyavskaya S.I., Lebedev A.V. The metabolic portrait of obese children. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2015;60(6):73-81. (In Russ.)

Просмотров: 632


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1027-4065 (Print)
ISSN 2500-2228 (Online)